BMPRII deficiency impairs apoptosis via the BMPRII-ALK1-BclX-mediated pathway in pulmonary arterial hypertension (PAH)

Human Molecular Genetics
H M ChowdhuryMd Talat Nasim

Abstract

Pulmonary Arterial Hypertension (PAH) is a devastating cardiovascular disorder characterised by the remodelling of pre-capillary pulmonary arteries. The vascular remodelling observed in PAH patients results from excessive proliferation and apoptosis resistance of pulmonary arterial smooth muscle (PASMCs) and endothelial cells (PAECs). We have previously demonstrated that mutations in the type II receptor for bone morphogenetic protein (BMPRII) underlie the majority of the familial and inherited forms of the disease. We have further demonstrated that BMPRII deficiency promotes excessive proliferation and attenuates apoptosis in PASMCs, but the underlying mechanisms remain unclear. The major objective of this study is to investigate how BMPRII deficiency impairs apoptosis in PAH. Using multidisciplinary approaches, we demonstrate that deficiency in the expression of BMPRII impairs apoptosis by modulating the alternative splicing of the apoptotic regulator, Bcl-x (B-cell lymphoma X) transcripts: a finding observed in circulating leukocytes and lungs of PAH subjects, hypoxia-induced PAH rat lungs as well as in PASMCs and PAECs. BMPRII deficiency elicits cell specific effects: promoting the expression of Bcl-xL transcripts in PASMCs...Continue Reading

References

Sep 5, 1998·Lancet·S P Gaine, L J Rubin
Sep 6, 2000·Nature Genetics·UNKNOWN International PPH ConsortiumR C Trembath
Mar 16, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·R C. Trembath
May 13, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Shen ZhangJason X-J Yuan
Mar 23, 2005·The Journal of Cell Biology·Hans-Georg KönigJochen H M Prehn
Nov 2, 2005·Journal of Bone and Mineral Metabolism·Kazuhito SugimoriIsao Kitajima
Feb 25, 2006·Circulation Research·Lu LongNicholas W Morrell
Oct 13, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Giorgio LagnaAkiko Hata
Feb 3, 2007·American Journal of Respiratory Cell and Molecular Biology·Yuichiro J SuzukiRegina M Day
Apr 5, 2007·Nature Protocols·Md Talat Nasim, Ian C Eperon
Jan 13, 2009·Cell Death and Differentiation·L C SpenderG J Inman
Jul 9, 2009·Journal of the American College of Cardiology·Nicholas W MorrellE Kenneth Weir
Nov 3, 2010·American Journal of Respiratory Cell and Molecular Biology·Ly TuChristophe Guignabert
Feb 19, 2013·American Journal of Respiratory Cell and Molecular Biology·Takeshi OgoMd Talat Nasim
Sep 24, 2015·Proceedings of the National Academy of Sciences of the United States of America·Meili ZhangThomas A Waldmann
Jan 8, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Rima Manafi ShabestariAhmad Kazemi
Oct 28, 2017·Cell Death and Differentiation·Joan Montero, Antony Letai
Apr 14, 2018·Nature Communications·Stefan GräfNicholas W Morrell
Jan 1, 2018·Cell Death and Differentiation·Joan Montero, Antony Letai

❮ Previous
Next ❯

Citations

May 10, 2021·Reproductive Sciences·Dongyong YangYanxiang Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.